Flavia Borellini
Direktor/Vorstandsmitglied bei REVOLUTION MEDICINES, INC.
Vermögen: 375 381 $ am 30.04.2024
Aktive Positionen von Flavia Borellini
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
REVOLUTION MEDICINES, INC. | Direktor/Vorstandsmitglied | 22.06.2021 | - |
Independent Dir/Board Member | 22.06.2021 | - | |
VIRACTA THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 14.08.2021 | - |
Independent Dir/Board Member | 14.08.2021 | - | |
CANTARGIA AB | Direktor/Vorstandsmitglied | 01.10.2020 | - |
Independent Dir/Board Member | 01.10.2020 | - | |
Kartos Therapeutics, Inc.
Kartos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kartos Therapeutics, Inc. is a clinical stage biopharmaceutical company based in Redwood City, CA. Kartos Therapeutics, Inc. is focused on developing a potential MDM2 inhibitor for the treatment of various TP53 wild-type hematological malignancies and solid tumors. The company was founded by Wayne P. Rothbaum and Iain David Dukes, and the CEO is Jesse Seton McGreivy. | Direktor/Vorstandsmitglied | 01.02.2018 | - |
Roche Group
Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Corporate Officer/Principal | - | - |
Karriereverlauf von Flavia Borellini
Ehemalige bekannte Positionen von Flavia Borellini
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ASTRAZENECA PLC | Corporate Officer/Principal | 01.09.2018 | 01.01.2020 |
Acerta Pharma BV
Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Acerta Pharma BV develops drugs for oncology and autoimmune diseases. It operates as a biotech company that combines technology platforms in drug discovery and development such as the covalent technology platform and the multiparametric phosphoflow cytometry platform. The company was founded by Allard Kaptein in 2012 and is headquartered in Oss, Netherlands. | Vorstandsvorsitzender | 01.02.2016 | 01.02.2019 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Corporate Officer/Principal | 01.10.2012 | 01.10.2013 |
Ausbildung von Flavia Borellini
Università degli Studi di Modena e Reggio Emilia | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 5 |
Niederlande | 2 |
Schweiz | 2 |
Operativ
Director/Board Member | 4 |
Independent Dir/Board Member | 3 |
Corporate Officer/Principal | 3 |
Sektoral
Health Technology | 8 |
Finance | 2 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 4 |
---|---|
REVOLUTION MEDICINES, INC. | Health Technology |
VIRACTA THERAPEUTICS, INC. | Health Technology |
CANTARGIA AB | Health Technology |
ASTRAZENECA PLC | Health Technology |
Private Unternehmen | 4 |
---|---|
Acerta Pharma BV
Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Acerta Pharma BV develops drugs for oncology and autoimmune diseases. It operates as a biotech company that combines technology platforms in drug discovery and development such as the covalent technology platform and the multiparametric phosphoflow cytometry platform. The company was founded by Allard Kaptein in 2012 and is headquartered in Oss, Netherlands. | Health Technology |
Kartos Therapeutics, Inc.
Kartos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kartos Therapeutics, Inc. is a clinical stage biopharmaceutical company based in Redwood City, CA. Kartos Therapeutics, Inc. is focused on developing a potential MDM2 inhibitor for the treatment of various TP53 wild-type hematological malignancies and solid tumors. The company was founded by Wayne P. Rothbaum and Iain David Dukes, and the CEO is Jesse Seton McGreivy. | Health Technology |
Roche Group
Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Finance |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
- Börse
- Insiders
- Flavia Borellini
- Erfahrung